{
    "clinical_study": {
        "@rank": "41682", 
        "arm_group": {
            "arm_group_label": "Group 1"
        }, 
        "brief_summary": {
            "textblock": "In this non-interventional one year study, data about overall and particularly\n      gastrointestinal tolerability, indications, cardiovascular risk factors and compliance are\n      collected by basic questionnaires, which are handed out by pharmacists to patients who\n      acquire (in Germany no prescription is needed) Rx (Prescription) or OTC (Over-The-counter)\n      Aspirin protect (enteric coated aspirin) 100 mg and are willing to participate in the study.\n      After 3, 6, 9 and 12 months follow-up questionnaires are sent out. Aim of the study is to\n      get information about safety, usage and compliance under everyday's conditions, because in\n      Germany low-dose aspirin is an OTC product with Rx indication."
        }, 
        "brief_title": "Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg", 
        "completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Aspirin", 
            "Drug Safety", 
            "Effects, Longterm"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who buy Aspirin protect 100 mg in a pharmacy and are willing to participate\n             in the study.\n\n        Exclusion Criteria:"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who buy Aspirin protect 100 mg with or without prescription in German pharmacies\n        and who are willing to participate in the study."
            }
        }, 
        "enrollment": {
            "#text": "4235", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669824", 
            "org_study_id": "12557", 
            "secondary_id": "MUE 053"
        }, 
        "intervention": {
            "arm_group_label": "Group 1", 
            "description": "Aspirin protect (enteric coated aspirin) 100 mg/single dose/day as long-term medication", 
            "intervention_name": "Acetylsalicylic acid (Aspirin, BAYE4465)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 17, 2012", 
        "link": [
            {
                "description": "Click here and search for drug information provided by the FDA.", 
                "url": "http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm"
            }, 
            {
                "description": "Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.", 
                "url": "http://www.fda.gov/medwatch/safety.htm"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Many Locations", 
                    "country": "Germany"
                }
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Tolerability, Compliance and Indications of Aspirin Protect 100 mg in Longterm Use (12 Months) Under Everyday's Conditions - Data Collection With Questionnaires Handed Out in Pharmacies to Aspirin Protect 100 mg Consumers", 
        "overall_official": {
            "affiliation": "Bayer", 
            "last_name": "Bayer Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: none", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "measure": "Overall and gastrointestinal tolerability assessed by questionnaire", 
            "safety_issue": "Yes", 
            "time_frame": "After 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669824"
        }, 
        "responsible_party": {
            "name_title": "Country Medical Director", 
            "organization": "Bayer Vital GmbH"
        }, 
        "source": "Bayer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2007", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}